The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors.
 
Ursula A. Matulonis
Honoraria - Advaxis; Alkermes; Symphogen
Consulting or Advisory Role - Agenus; AstraZeneca; Blueprint Medicines; GlaxoSmithKline; Merck; NextCure; Novartis; Trillium Therapeutics
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Filip Janku
Employment - Monte Rosa Therapeutics
Leadership - Monte Rosa Therapeutics
Stock and Other Ownership Interests - Cardiff Oncology; Monte Rosa Therapeutics
Consulting or Advisory Role - Cardiff Oncology; Deciphera; Fore Biotherapeutics; Fore Biotherapeutics; Foundation Medicine; Guardant Health; IDEAYA Biosciences; IFM Therapeutics; Immunomet; Jazz Pharmaceuticals; Novartis; Novartis; PureTech; Sequenom; Sotio; Synlogic; Valeant/Dendreon
Research Funding - Agios (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Fujifilm (Inst); Genentech (Inst); Novartis (Inst); Piqur (Inst); Plexxikon (Inst); Proximagen (Inst); Roche (Inst); Symphogen (Inst)
Other Relationship - Bio-Rad
 
Justin C Moser
Honoraria - Caris Life Sciences
 
Siqing Fu
Research Funding - Abbisko (Inst); BeiGene (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); Exelis (Inst); Exelis (Inst); Greenfire Bio (Inst); Hookipa Pharma (Inst); IMV (Inst); Innovent Biologics (Inst); K-Group Beta (Inst); Lilly (Inst); Lyvgen Biopharma (Inst); MacroGenics (Inst); Millennium (Inst); NCCN (Inst); Nerviano Medical Sciences (Inst); NeuPharma, Inc. (Inst); NextCure (Inst); NIH/NCI (Inst); Ningbo NewBay Medical Technology (Inst); Novartis (Inst); NovoCure (Inst); Parexel International, LLC (Inst); PureTech (Inst); Sellas Life Sciences (Inst); Soricimed (Inst); SQZ Biotech (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Taiho Oncology (Inst); Treadwell Therapeutics (Inst); Turnstone Bio (Inst); Tyligand Bioscience (Inst); Vaccibody (Inst)
 
David S. Wages
Stock and Other Ownership Interests - iSpecimen
Consulting or Advisory Role - AstraZeneca; FujiFilm; Myovant Sciences; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - iSpecimen
 
Catherine A. Wheeler
Leadership - Targovax
Stock and Other Ownership Interests - Exelixis; Exelixis; Exelixis; Targovax
Consulting or Advisory Role - Akrevia Therapeutics; Alacrita; CUE Biopharma; Dynamo Therapeutics; Exelixis; Fuji Pharma; Immunitas; KisoJi Biotechnology; Polyphor; Red Oak Medicines; Windmil
Travel, Accommodations, Expenses - Fuji Pharma; Targovax
 
Mikinaga Mori
Employment - Fujifilm
Leadership - Fujifilm
Patents, Royalties, Other Intellectual Property - Fujifilm
Travel, Accommodations, Expenses - Fujifilm
Other Relationship - Fujifilm
 
Susumu Shimoyama
Employment - Fujifilm
Leadership - Fujifilm
Patents, Royalties, Other Intellectual Property - Fujifilm
Travel, Accommodations, Expenses - Fujifilm
Other Relationship - Fujifilm
 
Naoki Yamada
Employment - Fujifilm
Leadership - Fujifilm
Stock and Other Ownership Interests - Fujifilm
Patents, Royalties, Other Intellectual Property - Fujifilm
 
Ruth Ann Subach
Employment - Fujifilm
Stock and Other Ownership Interests - Pfizer; Trevena
Travel, Accommodations, Expenses - Fujifilm; Palladio Biosciences
 
Kin Cheung
Stock and Other Ownership Interests - Moderna Therapeutics; Moderna Therapeutics (I)
Consulting or Advisory Role - Fujifilm
Research Funding - Fujifilm
Patents, Royalties, Other Intellectual Property - Fujifilm
 
Timothy Madden
Employment - Fujifilm; Fujifilm (I)
Consulting or Advisory Role - TD2/Volastra
Patents, Royalties, Other Intellectual Property - 60 patents held from my previous work as a faculty member at the University of Texas MD Anderson Cancer Center
Travel, Accommodations, Expenses - Fuji Pharma (I); Fujifilm
 
Gary Maier
Consulting or Advisory Role - Fujifilm
 
Mary Johansen
Employment - Fujifilm; Fujifilm (I)
Leadership - Fujifilm (I)
Stock and Other Ownership Interests - Reata Pharmaceuticals (I)
Consulting or Advisory Role - CNS Pharmaceuticals; CNS Pharmaceuticals (I); Inimmune (I); TD2 (I)
Patents, Royalties, Other Intellectual Property - MD Anderson Cancer Center (I)
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Honoraria - Rocky Mountain Oncology Society
Consulting or Advisory Role - EMD Serono; Fujifilm (Inst); Inspirna (Inst); Navire (Inst); Predicine (Inst); Regeneron (Inst); Silicon Therapeutics (Inst); Silicon Therapeutics (Inst); Turning Point Therapeutics (Inst)
Speakers' Bureau - Total Health Conferencing
Research Funding - 3-V Biosciences (Inst); Abbisko (Inst); Abbvie (Inst); ABL Bio (Inst); Accutar Biotech (Inst); ADC Therapeutics (Inst); Aileron Therapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Artios (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicycle Therapeutics (Inst); Bioatla (Inst); BioInvent (Inst); Biothera (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Celldex (Inst); Ciclomed (Inst); Curegenix (Inst); Curis (Inst); Cyteir (Inst); Daiichi (Inst); DelMar Pharmaceuticals (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Epizyme (Inst); Erasca, Inc (Inst); Erasca, Inc (Inst); Exelixis (Inst); Freenome (Inst); Fujifilm (Inst); Genmab (Inst); Hutchison MediPharma (Inst); IgM Biosciences (Inst); Ignyta (Inst); Immunogen/MacroGenics (Inst); Incyte (Inst); Jacobio (Inst); Jounce Therapeutics (Inst); Jubilant Pharmaceuticals (Inst); Kolltan Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); miRNA Therapeutics (Inst); Molecular Templates (Inst); Navire (Inst); NiKang Therapeutics (Inst); Novartis (Inst); OncoMed (Inst); Oncorus (Inst); Poseida (Inst); Precision Oncology (Inst); Prelude Therapeutics (Inst); PureTech (Inst); Pyramid Biosciences (Inst); RasCal (Inst); Regeneron (Inst); Relay Therapeutics (Inst); Rgenix (Inst); Ribon Therapeutics (Inst); Samumed (Inst); Sapience Therapeutics (Inst); Seagen (Inst); Silicon Therapeutics (Inst); Simcha Therapeutics (Inst); Sirnaomics (Inst); Strategia Therapeutics (Inst); Syndax (Inst); Synthorx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tarveda Therapeutics (Inst); TeneoBio (Inst); Tesaro (Inst); Tocagen (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EMD Serono; Fujifilm; Millennium; Sarah Cannon Research Institute